# Gilead Sciences Inc. (GILD): SI in SEC Filings | SI Exposure > Gilead Sciences Inc. (GILD): 35.7% of its 10-K, 10-Q and 8-K filings in the last four quarters say "artificial intelligence". No "super intelligence" yet. Source: https://tsio.si/exposure/gild/ Updated: 2026-11-11 Publisher: The SI Observatory (tsio.si), run by the SI community, built by Codeflex 1. [Home](https://tsio.si/) 2. [SI Exposure](https://tsio.si/exposure/) 3. Gilead Sciences Inc. (GILD) SI Exposure · Rank 34 of 100 · Health Care # Gilead Sciences Inc. (GILD) and SI **5 of Gilead Sciences Inc.'s 14 10-K, 10-Q and 8-K filings in the last four full quarters (Q4 2025 to Q3 2026) contain "artificial intelligence" or the new name: 35.7%, rank 34 of the 100 largest US companies.** It has not used the new name, "super intelligence" or "superintelligence", in any SEC filing so far. Counts come from SEC EDGAR full text search, Nov 11, 2026. Updated **Nov 11, 2026** · SEC CIK [882095](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000882095) · Sector **Health Care** By quarter [The full ranking](https://tsio.si/exposure/#ranking) [Share on X](https://x.com/intent/post?text=Gilead+Sciences+Inc.+and+SI%3A+35.7%25+of+its+10-K%2C+10-Q+and+8-K+filings+now+contain+the+phrase%2C+rank+34+of+100.+From+SEC+EDGAR%3A&url=https%3A%2F%2Ftsio.si%2Fexposure%2Fgild%2F) - **Share, last 4 quarters**: 35.7% - **Filings with the phrase**: 5 - **New name, all time**: 0 - **Rank of 100**: 34 Over time ## Gilead Sciences Inc. filings, quarter by quarter Since Q1 2023: how many 10-K, 10-Q and 8-K filings Gilead Sciences Inc. made each quarter and how many contain "artificial intelligence" or "super intelligence" or "superintelligence". *Chart: Share of Gilead Sciences Inc. 10-K, 10-Q and 8-K filings that contain either name. Per calendar quarter; Q4 2026 runs to Nov 11, 2026.* | Quarter | Filings | Old name | New name | Share | |---|---|---|---|---| | Q4 2026 | 2 | 1 | 0 | 50.0% | | Q3 2026 | 2 | 1 | 0 | 50.0% | | Q2 2026 | 5 | 1 | 0 | 20.0% | | Q1 2026 | 3 | 2 | 0 | 66.7% | | Q4 2025 | 4 | 1 | 0 | 25.0% | | Q3 2025 | 4 | 1 | 0 | 25.0% | | Q2 2025 | 3 | 1 | 0 | 33.3% | | Q1 2025 | 3 | 2 | 0 | 66.7% | | Q4 2024 | 3 | 1 | 0 | 33.3% | | Q3 2024 | 3 | 0 | 0 | 0.0% | | Q2 2024 | 3 | 0 | 0 | 0.0% | | Q1 2024 | 6 | 0 | 0 | 0.0% | | Q4 2023 | 2 | 0 | 0 | 0.0% | | Q3 2023 | 4 | 0 | 0 | 0.0% | | Q2 2023 | 3 | 0 | 0 | 0.0% | | Q1 2023 | 3 | 0 | 0 | 0.0% | 10-K, 10-Q and 8-K filings by calendar quarter. Old name: filings with "artificial intelligence". New name: filings with "super intelligence" or "superintelligence". A filing with both counts once in the share. ## Filings with the new name None yet. When Gilead Sciences Inc. first files a document with "super intelligence" or "superintelligence", it appears here with a link. ## Latest filings with "artificial intelligence" 1. Oct 30, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209526000039/gild-20260930.htm) 0000882095-26-000039 2. Aug 6, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm) 0000882095-26-000031 3. May 7, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209526000024/gild-20260331.htm) 0000882095-26-000024 4. Feb 24, 2026 [10-K](https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/gild-20251231.htm) 0000882095-26-000006 5. Feb 23, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/882095/000110465926018314/tm267044d1_ex2-1.htm) 0001104659-26-018314 6. Nov 7, 2025 [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209525000047/gild-20250930.htm) 0000882095-25-000047 7. Aug 7, 2025 [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209525000032/gild-20250630.htm) 0000882095-25-000032 8. May 7, 2025 [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209525000012/gild-20250331.htm) 0000882095-25-000012 9. Feb 28, 2025 [10-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000006/gild-20241231.htm) 0000882095-25-000006 10. Feb 11, 2025 [8-K](https://www.sec.gov/Archives/edgar/data/882095/000088209525000003/exhibit991earningspressrel.htm) 0000882095-25-000003 11. Nov 12, 2024 [10-Q](https://www.sec.gov/Archives/edgar/data/882095/000088209524000028/gild-20240930.htm) 0000882095-24-000028 Embed ## Put this card on any page A plain image that links back here: no script, no cookies. It shows the latest build's numbers and its source. Free to use under CC BY 4.0. Copy the embed ``` SI Exposure of Gilead Sciences Inc.: 35.7% of its 10-K, 10-Q and 8-K filings contain "artificial intelligence" ``` ![SI Exposure card for Gilead Sciences Inc.](https://tsio.si/exposure/gild/card.svg) Compare ## Neighbors in the ranking and sector peers [Rank 32 · Technology**Marvell Technology Inc.**36.4% of filings · 0 with the new name](https://tsio.si/exposure/mrvl/) [Rank 33 · Technology**Lam Research Corporation**36.4% of filings · 0 with the new name](https://tsio.si/exposure/lrcx/) [Rank 35 · Health Care**UnitedHealth Group Incorporated**33.3% of filings · 0 with the new name](https://tsio.si/exposure/unh/) [Rank 36 · Consumer Discretionary**Uber Technologies Inc.**33.3% of filings · 0 with the new name](https://tsio.si/exposure/uber/) [Rank 5 · Health Care**Eli Lilly and Company**72.7% of filings · 0 with the new name](https://tsio.si/exposure/lly/) [Rank 7 · Health Care**Pfizer Inc.**71.4% of filings · 0 with the new name](https://tsio.si/exposure/pfe/)